Article

Dr. Budenz named chairman

Donald L. Budenz, MD, MPH, will become chair of the department of ophthalmology at the University of North Carolina at Chapel Hill effective October 1. He will replace Travis Meredith, MD, who is stepping down after serving as chair of the department since 2001. Dr. Meredith will continue to work part-time as chairman emeritus and professor of ophthalmology.

Chapel Hill, NC-Donald L. Budenz, MD, MPH, will become chairman of the department of ophthalmology at the University of North Carolina at Chapel Hill effective Oct. 1. He will replace Travis Meredith, MD, who is stepping down after serving as chairman of the department since 2001. Dr. Meredith will continue to work part-time as chairman emeritus and professor of ophthalmology.

Dr. Budenz is a professor at the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine. He has also served as associate medical director of the Bascom Palmer Eye Institute and chair of its quality assurance committee. He specializes in cataracts and glaucoma, and his research focuses on glaucoma diagnostic testing, epidemiology, and surgical clinical trials in glaucoma.

After graduating from the University of Pennsylvania, Dr. Budenz earned his medical degree at Harvard Medical School. He completed his residency in ophthalmology at the Scheie Eye Institute at the University of Pennsylvania and a glaucoma fellowship at the University of Miami. Dr. Budenz also received his Master of Public Health degree from the Johns Hopkins Bloomberg School of Public Health.

Dr. Budenz is actively engaged in global health initiatives. He travels to Ghana each year to treat patients and to train local surgeons. For the past 15 years, he has conducted several clinical trials and studied the epidemiology of blindness, visual impairment, and glaucoma in that country.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.